№ US20260001880A1발명
심사 중Bicyclic DGK Inhibitors
Bicyclic DGK Inhibitors
The present application provides bicyclic compounds that modulate the activity of diacylglycerol kinase (DGK), which are useful in the treatment of various diseases, including cancer.
❖Incyte CorporationJoshua Hummel; Liana Hie; Jacob J. Lacharity; Xiaolei Li; Xiaozhao Wang; Bo Wei; Sarah Winterton§ 1/55 청구항C7D 473/18, A61K 31/4545, A61K 31/519 +5